首页> 外国专利> Method for treating cataract complicated with anterior uveitis

Method for treating cataract complicated with anterior uveitis

机译:白内障并发前葡萄膜炎的治疗方法

摘要

The invention relates to medicine, in particular for ophthalmology and can be used for treating cataract complicated with anterior uveitis.According to the invention, the method consists in that preoperatively is parabulbarly administered 1 ml of solution containing Betamethasone disodium phosphate 2 mg, Betamethasone dipropionate 5 mg and vehicle up to 1 ml, once, then are carried out 3 intravenous perfusions in 1 day with Dexamethasone solution, in a dose of 0.5 mg/kg body weight per day, dissolved in 200 ml of 0.9% NaCl solution, then the administered dose is reduced by half and are carried out 2…3 perfusions in 1 day, then in the anterior chamber of the eye is administered once Bevacizumab solution, in a dose of 10…15 mg, dissolved in 0.1…0.2 ml of 0.9 % NaCl solution, in 12…15 days after the administration of Bevacizumab solution is carried out a surgical intervention by the phacoemulsification method with implantation of the artificial lens, and from the 1st postoperative day for 10…14 days are topically administered eye drops of 0.1% Dexamethasone solution, 2 drops, 3 times a day.
机译:本发明涉及特别是用于眼科的药物,并且可以用于治疗白内障并发前葡萄膜炎。根据本发明,该方法包括在术前给与1ml含倍他米松磷酸二氢钠2mg,倍他米松二丙酸酯5的溶液。毫克和最多1毫升的溶媒一次,然后每天以0.5毫克/千克体重的剂量用地塞米松溶液进行3次静脉内灌注,溶于200毫升0.9%的氯化钠溶液中,然后给药剂量减半,并在1天之内进行2…3灌注,然后在眼睛前房中施用一次Bevacizumab溶液,剂量为10…15 mg,溶于0.1…0.2 ml的0.9%NaCl中在使用贝伐单抗溶液后的12…15天内,通过超声乳化术并植入人工晶状体进行手术干预,从术后第一天开始10到14天局部给药0.1%地塞米松溶液的眼药水,每天2次,每天3次。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号